KRISTINE-GEM ESTRELLA: Open Payments
NPI 1659961738 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 35 payments from 10 companies in 2025. Trend: 2023 $630 · 2024 $2,210 · 2025 $1,400
Food & beverage: $1,315Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $461 |
| ABBVIE INC. | 16 | $322 |
| GENZYME CORPORATION | 2 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Organon LLC | 2 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| Janssen Biotech, Inc. | 2 | $80 |
| Galderma Laboratories, L.P. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| Incyte Corporation | 1 | $16 |
Products named: Bimzelx, SKYRIZI, SPEVIGO, DUPIXENT, VTAMA, TREMFYA, RINVOQ, AKLIEF.
Industry payments across NV — which companies pay providers there.
